Uppsala, Sweden – October 14 – Viedoc, a leading provider of digital eClinical solutions, together with LINK Medical, a prominent Nordic CRO and Regulatory service provider, has successfully completed a pilot for a large, multi-country consumer health products real-world evidence (RWE) study. The pilot tested a fully digital approach to participant recruitment and engagement—an area still relatively rare in real-world research—and demonstrated how integrated eClinical technologies can help scale studies to tens of thousands of participants.
Addressing challenges in digital participant engagement
As real-world and long-term clinical studies become more ambitious, CROs like LINK Medical are facing increasing challenges in digitally engaging participants—from recruitment to long-term follow-up. After evaluating existing market solutions and finding them fragmented, complex, and poorly integrated with modern eClinical systems, LINK turned to Viedoc, a trusted partner and EDC market leader with whom they have a long history of collaboration.
To address this challenge, Viedoc developed a comprehensive digital solution covering the entire patient journey: recruitment, eConsent, ePRO, continuous communication, and digital compensation—fully integrated and compliant with ICH E6(R3) and other regulatory standards.
Insights from LINK Medical's RWE pilot
Ahead of a planned 10-year public health observational study involving up to 100,000 participants across four Nordic countries, the sponsor conducted a digital pilot using the solution. The pilot included a large-scale online survey to validate the platform and the study’s digital-first methodology, and revealed clear benefits:
High engagement: 88% of invited participants entered the survey website, and 85% rated the overall process as smooth and easy.
Strong participant follow-through: Once consent was signed, almost all participants completed the full process, showing the solution’s ability to keep users engaged.
Motivation for long-term participation: Over 90% expressed willingness to repeat shorter annual surveys, and most respondents viewed digital compensation positively.
Besides meeting regulatory and technical requirements, these findings validate the positive participant experience that will help sponsors identify and address real-world enrollment challenges before scaling up research,” said Bob Egner, Chief Product Officer at Viedoc. “We strive to put participants first when designing digital experiences.”
The success of this pilot also underscores the importance of close collaboration between technology providers and CROs. By combining deep domain expertise with modern digital tools, the project has shown how data collection in large-scale, multi-country studies can be both efficient and participant-friendly.
“It’s been a true pleasure to see Viedoc’s innovative approach come to life from our original idea and request to a fully functioning virtual tool. We’ve been closely collaborating as companies together with the sponsor for months on how to solve all challenges, particularly around self-service, adherence, and subject retention. Both LINK Medical and the sponsor felt that the right solution wasn’t available on the market, and we have been very pleased to see the pilot confirm that the innovative solution built by Viedoc fulfills all the needs,” says Hedda Magnusson, Director RWE at LINK Medical.
Looking ahead, the positive feedback and strong results from this pilot suggest that the solution can be applied across other real-world evidence and distributed studies. Viedoc is now prioritizing development of more configurable options, with the goal of making the solution generally available for future research with similar requirements.
